Antagonism of psychostimulant 2-phenyl-5,5-dimethyl-tetrahydro-1,4-oxazine hydrochloride (G 130) to central nervous system depressing drugs. Monoamine oxidase inhibitory activity and norepinephrine and serotonin induced changes. Comparison with dL-amphetamine.
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D000928:Antidepressive Agents / Q000037:antagonists & inhibitors*; D001763:Blepharoptosis / Q000517:prevention & control; D001831:Body Temperature / Q000187:drug effects; D001933:Brain Stem / Q000032:analysis; D002746:Chlorpromazine / Q000037:antagonists & inhibitors; D004027:Diencephalon / Q000032:analysis; D005260:Female; D008297:Male; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects; D009206:Myocardium / Q000032:analysis; D009638:Norepinephrine / Q000032:analysis / Q000037:antagonists & inhibitors*; D010078:Oxazines / Q000494:pharmacology*; D010424:Pentobarbital / Q000037:antagonists & inhibitors; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D012701:Serotonin / Q000032:analysis; D012702:Serotonin Antagonists; D012890:Sleep / Q000187:drug effects; D013268:Stimulation, Chemical
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D010078:Oxazines; D012702:Serotonin Antagonists; D012701:Serotonin; D012110:Reserpine; D000661:Amphetamine; D010424:Pentobarbital; D002746:Chlorpromazine; D009638:Norepinephrine